CELL & GENE THERAPY INSIGHTS

Spotlight

Preclinical/translational tools and strategies

Feb 2021
Guest Editor:
Bruce Bunnell, Professor and Chair at UNT Health Science Center
Bruce Bunnell
Professor and Chair at UNT Health Science Center

Foreword

Preclinical/translational tools & strategies

Bruce A Bunnell
24 February 2021
Foreword

Editorial


Expert Insight

The T cell therapy field faces preclinical and translational R&D challenges as it targets more complex diseases

Gary Waanders,
Silke Raffegerst,
Petra Prinz-Schulz,
Maja Buerdek
15 February 2021
Expert Insight

Animal models of disease: preclinical to clinical gene therapy translatability

Erika Matsumoto Plata,
Carlos R Plata-Salamán
11 February 2021
Expert Insight

Commentary

Expediting novel ex vivo HSC gene therapies to the clinic: a preclinical perspective

Giulia Leoni,
Andy Lambert,
Charlotte Hudson,
Chiara Recchi,
Marina Cattoni,
Paul Heal
24 February 2021
Commentary

Interview


Podcast


FastFacts

Identify and select optimal T cell phenotypes

James Lovrgen
22 February 2021
FastFacts

Report

Expert Insight

Business Insight: cell & gene therapy

Jackie Mulryne,
Dr Beatriz San Martin,
John Schmidt,
Ewan Townsend
1 February 2021
Expert Insight

Other articles

Innovator Insight

Optimization of AAV process development: transfection matters

Kelsey Wosnitzka,
Shandel Pariag ,
Hélène Trottin ,
Dr Alengo Nyamay’antu,
Mathieu Porte ,
Malik Hellal,
Patrick Erbacher
14 January 2021
Innovator Insight

Interview

Get in line: developing in-process analytical tools for gene therapy applications

René Gantier,
Ramsey Shanbaky,
Jay West
10 February 2021
Interview

Podcast

Get in line: developing in-process analytical tools for gene therapy applications

René Gantier,
Ramsey Shanbaky,
Jay West
10 February 2021
Podcast

Translation Insight

Flow cytometric analysis for cellular therapy products: design and practical considerations

Alison J Thomson,
Laura Bailey,
John DM Campbell
26 January 2021
Translation Insight

FastFacts

Webinars

Case study: Optimization of lentiviral vector production from early stages to GMP

Case study: Optimization of lentiviral vector production from early stages to GMP

Claire Wartel-Weill
Claire Wartel-Weill, Director of Quality and Compliance, Polyplus-transfection
Natalia Elizalde
Natalia Elizalde, Business Development Director, VIVEviotech
Rakel López de Maturana
Rakel López de Maturana, Qualified Person, VIVEBiotech
19 January 2021
Webinar
Breaking barriers in viral vector titer analysis speed, volume, and data quality

Breaking barriers in viral vector titer analysis speed, volume, and data quality

Robert Durham, PhD
Robert Durham, PhD, Director of Service and Scientific Support, Gyros Protein Technologies
Johannes Stanta, PhD
Johannes Stanta, PhD, Director of Bioanalysis, Freeline Therapeutics
Katherine Hanson, PhD
Katherine Hanson, PhD, Lab Manager, PPD Laboratories
Judith Greengard
Judith Greengard, Senior Scientific Fellow, Exploratory Analytical Development and Validation, Adverum Biotechnologies, Inc.
27 January 2021
Webinar
Supporting development of mRNA-based therapies by addressing large scale purification challenges

Supporting development of mRNA-based therapies by addressing large scale purification challenges

Kelly Flook
Kelly Flook, Senior Product Manager, Purification, Bioproduction Division, Thermofisher scientific
9 February 2021
Webinar
Exploring the capabilities of a versatile, novel, automated closed system for cell and gene therapy manufacturing

Exploring the capabilities of a versatile, novel, automated closed system for cell and gene therapy manufacturing

Premkumar Jayaraman, PhD
Premkumar Jayaraman, PhD, Regional Field Application Scientist, APJ (Cell & Gene Therapy), Thermo Fisher Scientific
Sarah Daoudi
Sarah Daoudi, Scientist III, Field Applications, Thermo Fisher Scientific
16 February 2021
Webinar
Large-scale LVV production: from industry-leading process development to high quality GMP vector

Large-scale LVV production: from industry-leading process development to high quality GMP vector

Dr Giuliana Vallanti
Dr Giuliana Vallanti , Director, Development and Global R&D, Cell and Gene, AGC Biologics
Professor Alessandro Aiuti
Professor Alessandro Aiuti , Deputy Director, Clinical Research, San Raffaele Telethon Institute for Gene Therapy (SR-TIGET)
Dr Marianna Sabatino
Dr Marianna Sabatino , Head of Product Sciences, Autolus Ltd
25 February 2021
Webinar
Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

Harnessing the power of tumor-infiltrating lymphocytes for cell therapy

Dr Sandy Pelletier
Dr Sandy Pelletier, Scientific Coordinator, Adoptive Cell Transfer (ACT) Immunotherapy Program, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)
Felix Eppler, PhD
Felix Eppler, PhD, Group Leader, Cell Sorting Product Management, Miltenyi Biotec
Niloufar Monhasery
Niloufar Monhasery, Global Product Manager, Miltenyi Biotec
3 March 2021
Webinar